Market's view on Feedback
Published on April 2024
- There are expressions of frustration with the lack of progress and action from the company leadership, with comments pointing out repeated instances of all talk and no substantial outcomes.
- Concerns are raised about the company’s ongoing high cash burn rate and the potential need for future fundraising to sustain operations.
- Speculation and hope are shared regarding potential positive announcements, but historical precedence sets a tone of skepticism.
- Comparisons are drawn between the company’s performance and the broader AIM market, with discussions about the reputation of AIM for eroding shareholder value and the need for delisting low-quality companies to improve the market’s image.
- Observations are made about the company’s participation in pilot projects in India leading to awards but not resulting in significant contract wins or financial success.
- Comments indicate a strong desire for tangible results from pilot projects and speculative discussions about potential discussions and presentations by company leadership in upcoming events.
- Discussions about other companies like Alliance Pharma are briefly mentioned in the context of stock movements and dividends.